Oncolytics Biotech logo

Oncolytics Biotech Share Price Today

(NASDAQ: ONCY)

Oncolytics Biotech share price is $0.74 & ₹64.36 as on 6 Mar 2025, 2.30 'hrs' IST

$0.74

0.09

(13.52%)

Market is closed - opens 8 PM, 06 Mar 2025

View live Oncolytics Biotech share price in Dollar and Rupees. Guide to invest in Oncolytics Biotech stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Oncolytics Biotech, along with analyst recommendations, forecasts, and comprehensive financials.

Oncolytics Biotech share price movements

  • Today's Low: $0.65
    Today's High: $0.75

    Day's Volatility :13.33%

  • 52 Weeks Low: $0.65
    52 Weeks High: $1.53

    52 Weeks Volatility :57.53%

Oncolytics Biotech (ONCY) Returns

PeriodOncolytics Biotech IncIndex (Russel 2000)
3 Months
-24.86%
0.0%
6 Months
-34.21%
0.0%
1 Year
-37.5%
0.0%
3 Years
-57.52%
-11.6%

Oncolytics Biotech (ONCY) Key Statistics

in dollars & INR

Previous Close
$0.65
Open
$0.65
Today's High
$0.75
Today's Low
$0.65
Market Capitalization
$51.1M
Today's Volume
$39.9K
52 Week High
$1.53
52 Week Low
$0.6498
Revenue TTM
$0.0
EBITDA
$-35.3M
Earnings Per Share (EPS)
$-0.25
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-145.2%

How to invest in Oncolytics Biotech Stock (ONCY) from India?

It is very easy for Indian residents to invest directly in Oncolytics Biotech from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Oncolytics Biotech stock in both Indian Rupees (INR) and US Dollars (USD). Search for Oncolytics Biotech or ONCY on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Oncolytics Biotech or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Oncolytics Biotech shares which would translate to 1.175 fractional shares of Oncolytics Biotech as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Oncolytics Biotech, in just a few clicks!

Returns in Oncolytics Biotech (ONCY) for Indian investors in Rupees

The Oncolytics Biotech stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Oncolytics Biotech investment value today

Current value as on today

₹76,117

Returns

₹23,883

(-23.88%)

Returns from Oncolytics Biotech Stock

₹28,846 (-28.85%)

Dollar Returns

₹4,963 (+4.96%)

Indian investors sentiment towards Oncolytics Biotech (ONCY)

31%

Period: Feb 3, 2025 to Mar 5, 2025. Change in 30 Days versus previous period

Search interest for Oncolytics Biotech Stock from India on INDmoney has increased by 31% in the last 30 days, reflecting an upward trend in search activity.

Global Institutional Holdings in Oncolytics Biotech

  • SEEDS INVESTOR LLC

    0.25%

  • International Assets Investment Management, LLC

    0.23%

  • Goldman Sachs Group Inc

    0.13%

  • Virtu Financial LLC

    0.13%

  • Geode Capital Management, LLC

    0.09%

  • Royal Bank of Canada

    0.08%

Analyst Recommendation on Oncolytics Biotech

Buy

    90%Buy

    9%Hold

    0%Sell

Based on 11 Wall street analysts offering stock ratings for Oncolytics Biotech(by analysts ranked 0 to 5 stars)

Based on 11 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
10
9
9
Hold
1
1
1
Sell
0
0
0

Analyst Forecast on Oncolytics Biotech Stock (ONCY)

What analysts predicted

Upside of 557.84%

Target:

$4.87

Current:

$0.74

Insights on Oncolytics Biotech Stock (Ticker Symbol: ONCY)

  • Price Movement

    In the last 6 months, ONCY stock has moved down by -34.2%
  • ONCY vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 62.3% return, outperforming this stock by 99.2%
  • ONCY vs VRTX (3 yr)

    In the last 3 years, Vertex Pharmaceuticals Incorporated has given 47.7% return, outperforming this stock by 104.9%

Oncolytics Biotech Technicals Summary

Sell

Neutral

Buy

Oncolytics Biotech is currently in a neutral trading position according to technical analysis indicators.

Oncolytics Biotech (ONCY) Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Oncolytics Biotech Inc logo
-6.41%
-34.21%
-37.5%
-57.52%
-66.32%
Regeneron Pharmaceuticals, Inc. logo
1.3%
-41.29%
-30.51%
9.2%
42.38%
Beone Medicines Ltd logo
15.19%
34.31%
61.3%
43.16%
68.1%
Vertex Pharmaceuticals Incorporated logo
3.37%
3.77%
18.06%
106.43%
121.36%
Alnylam Pharmaceuticals, Inc. logo
-11.52%
-3.4%
62.32%
49.04%
120.93%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Oncolytics Biotech Inc logo
NA
NA
NA
-0.45
-1.45
-0.63
NA
0.12
Regeneron Pharmaceuticals, Inc. logo
17.85
17.85
1.03
43.09
0.16
0.07
0.01
273.57
Beone Medicines Ltd logo
NA
NA
NA
1.43
-0.19
-0.06
NA
31.22
Vertex Pharmaceuticals Incorporated logo
32.84
NA
1.33
18.07
-0.03
0.13
NA
63.87
Alnylam Pharmaceuticals, Inc. logo
NA
NA
-0.49
0.57
-15.01
-0.03
NA
0.52
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Oncolytics Biotech Inc logo
Buy
$51.1M
-66.32%
NA
0.0%
Regeneron Pharmaceuticals, Inc. logo
Buy
$74.9B
42.38%
17.85
31.07%
Beone Medicines Ltd logo
NA
$28.5B
68.1%
NA
-16.92%
Vertex Pharmaceuticals Incorporated logo
Buy
$124.1B
121.36%
32.84
-4.86%
Alnylam Pharmaceuticals, Inc. logo
Buy
$31.5B
120.93%
NA
-12.37%

About Oncolytics Biotech

Oncolytics Biotech Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of pharmaceutical products for the treatment of cancer. The company is developing pelareorep, an intravenously delivered immunotherapeutic agent, which is in phase 3 clinical trial for the treatment of hormone receptor-positive / human epidermal growth factor 2-negative metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma. It has a co-development agreement with Merck KGaA and Pfizer Inc. to co-develop pelareorep, as well as with Roche Holding AG. The company was incorporated in 1998 and is headquartered in Calgary, Canada.
Organization
Oncolytics Biotech
Employees
0
CEO
Mr. Wayne F. Pisano M.B.A.
Industry
Health Technology

Management People of Oncolytics Biotech

NameTitle
Mr. Wayne F. Pisano M.B.A.
Interim CEO & Chairman of the Board
Mr. Kirk J. Look C.A., CA
Chief Financial Officer
Dr. Thomas C. Heineman M.D., Ph.D.
Chief Medical Officer
Ms. Allison Hagerman P.Eng., P.M.P.
Vice President of Product Development
Ms. Amy Goodowitz Levin B.S.N., R.N.
Vice President of Clinical Operations
Jon Patton
Director of Investor Relations & Communication
Mr. John Mark Lievonen B.B.A., CM, F.C.A., FCPA, LLD, M.B.A.
Consultant

Important FAQs about investing in ONCY Stock from India :

What is Oncolytics Biotech share price today?

Oncolytics Biotech share price today stands at $0.74, Open: $0.65 ; Previous Close: $0.65 ; High: $0.75 ; Low: $0.65 ; 52 Week High: $1.53 ; 52 Week Low: $0.65.

The stock opens at $0.65, after a previous close of $0.65. The stock reached a daily high of $0.75 and a low of $0.65, with a 52-week high of $1.53 and a 52-week low of $0.65.

Can Indians buy Oncolytics Biotech shares?

Yes, Indians can invest in the Oncolytics Biotech (ONCY) from India.

With INDmoney, you can buy Oncolytics Biotech at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Oncolytics Biotech at zero transaction cost.

How can I buy Oncolytics Biotech shares from India?

It is very easy to buy Oncolytics Biotech from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Oncolytics Biotech (ONCY) be purchased?

Yes, you can buy fractional shares of Oncolytics Biotech with INDmoney app.

What are the documents required to start investing in Oncolytics Biotech stocks?

To start investing in Oncolytics Biotech, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Oncolytics Biotech Stock (ONCY)?

Today’s highest price of Oncolytics Biotech (ONCY) is $0.75.

Today’s lowest price of Oncolytics Biotech (ONCY) is $0.65.

What is today's market capitalisation of Oncolytics Biotech?

Today's market capitalisation of Oncolytics Biotech ONCY is 51.1M

What is the 52 Week High and Low Range of Oncolytics Biotech Stock (ONCY)?

  • 52 Week High

    $1.53

  • 52 Week Low

    $0.65

What are the historical returns of Oncolytics Biotech (ONCY)?

  • 1 Month Returns

    -6.41%

  • 3 Months Returns

    -34.21%

  • 1 Year Returns

    -37.5%

  • 5 Years Returns

    -66.32%

Who is the Chief Executive Officer (CEO) of Oncolytics Biotech ?

Mr. Wayne F. Pisano M.B.A. is the current Chief Executive Officer (CEO) of Oncolytics Biotech.